Friday, August 16, 2024 9:35:58 AM
Yes I do believe that IF our CEO+ accepts a substantial settlement it will benefit all shareholders of nwbo and show up on the balance sheet and cash flows, which It would have to if I play accountant, which I am not.
If I were a fudster or short I might be needing to keep vaseline handy because they say turnabout is fair game
We long time longs have little more to risk now that we await first approval without serious rationale for not approving the MAA of the only improvement in the lot of GBM patients and it doesn’t even have side effects imo!!!
The FUDsters have long shown their hand as perma negatives that can very reasonably be taken as biased and organized against nwbo and demonstrated as continuing false negative narratives.
In short (no pun intended maybe) FUDsters have zero credibility at this point!!!
If I were a fudster or short I might be needing to keep vaseline handy because they say turnabout is fair game
We long time longs have little more to risk now that we await first approval without serious rationale for not approving the MAA of the only improvement in the lot of GBM patients and it doesn’t even have side effects imo!!!
The FUDsters have long shown their hand as perma negatives that can very reasonably be taken as biased and organized against nwbo and demonstrated as continuing false negative narratives.
In short (no pun intended maybe) FUDsters have zero credibility at this point!!!
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
